<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34018075</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions.</ArticleTitle><Pagination><StartPage>3145</StartPage><EndPage>3166</EndPage><MedlinePgn>3145-3166</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05328-6</ELocationID><Abstract><AbstractText>The prominent causes for motor neuron diseases like ALS are demyelination, immune dysregulation, and neuroinflammation. Numerous research studies indicate that the downregulation of IGF-1 and GLP-1 signaling pathways plays a significant role in the progression of ALS pathogenesis and other neurological disorders. In the current review, we discussed the dysregulation of IGF-1/GLP-1 signaling in neurodegenerative manifestations of ALS like a genetic anomaly, oligodendrocyte degradation, demyelination, glial overactivation, immune deregulation, and neuroexcitation. In addition, the current review reveals the IGF-1 and GLP-1 activators based on the premise that the restoration of abnormal IGF-1/GLP-1 signaling could result in neuroprotection and neurotrophic effects for the clinical-pathological presentation of ALS and other brain diseases. Thus, the potential benefits of IGF-1/GLP-1 signal upregulation in the development of disease-modifying therapeutic strategies may prevent ALS and associated neurocomplications.</AbstractText><CopyrightInformation>&#xa9; 2021. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shandilya</LastName><ForeName>Ambika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, 142001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehan</LastName><ForeName>Sidharth</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0034-835X</Identifier><AffiliationInfo><Affiliation>Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, 142001, India. sidh.mehan@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67763-96-6</RegistryNumber><NameOfSubstance UI="D007334">Insulin-Like Growth Factor I</NameOfSubstance></Chemical><Chemical><RegistryNumber>89750-14-1</RegistryNumber><NameOfSubstance UI="D052216">Glucagon-Like Peptide 1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052216" MajorTopicYN="N">Glucagon-Like Peptide 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007334" MajorTopicYN="Y">Insulin-Like Growth Factor I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Demyelination</Keyword><Keyword MajorTopicYN="N">GLP-1</Keyword><Keyword MajorTopicYN="N">Genetic dysfunction</Keyword><Keyword MajorTopicYN="N">IGF-1</Keyword><Keyword MajorTopicYN="N">Immune dysregulation</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34018075</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05328-6</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05328-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR (1994) Hormonal and nutritional regulation of IGF-I and its binding proteins. Hormone Research in Paediatrics 42(4-5):145&#x2013;151</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000184187</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253(8):2769&#x2013;2776</Citation><ArticleIdList><ArticleId IdType="pubmed">632300</ArticleId><ArticleId IdType="doi">10.1016/S0021-9258(17)40889-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Withers DJ, White M (2000) Perspective: the insulin signaling system&#x2014;a common link in the pathogenesis of type 2 diabetes. Endocrinology 141(6):1917&#x2013;1921</Citation><ArticleIdList><ArticleId IdType="pubmed">10830270</ArticleId><ArticleId IdType="doi">10.1210/endo.141.6.7584</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemmons DR (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8(1):45&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">9174662</ArticleId><ArticleId IdType="doi">10.1016/S1359-6101(96)00053-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Baragli A, Lanfranco F, Allasia S, Granata R, Ghigo E (2011) Neuroendocrine and metabolic activities of ghrelin gene products. Peptides. 32(11):2323&#x2013;2332</Citation><ArticleIdList><ArticleId IdType="pubmed">22056513</ArticleId><ArticleId IdType="doi">10.1016/j.peptides.2011.10.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel T (2013) Insulin/IGF-signalling in embryonic and adult neural proliferation and differentiation in the mammalian central nervous system. Trends in Cell Signaling Pathways in Neuronal Fate Decision, 38-73.</Citation></Reference><Reference><Citation>Laviola L, Natalicchio A, Giorgino F (2007) The IGF-I signaling pathway. Curr Pharm Des 13(7):663&#x2013;669</Citation><ArticleIdList><ArticleId IdType="pubmed">17346182</ArticleId><ArticleId IdType="doi">10.2174/138161207780249146</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH (2003) Glucagon-like peptide-1 decreases endogenous amyloid-&#x3b2; peptide (A&#x3b2;) levels and protects hippocampal neurons from death induced by A&#x3b2; and iron. J Neurosci Res 72(5):603&#x2013;612</Citation><ArticleIdList><ArticleId IdType="pubmed">12749025</ArticleId><ArticleId IdType="doi">10.1002/jnr.10611</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggio LL, Drucker DJ (2007 May) Biology of incretins: GLP-1 and GIP. Gastroenterology. 132(6):2131&#x2013;2157. https://doi.org/10.1053/j.gastro.2007.03.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2007.03.054</ArticleId><ArticleId IdType="pubmed">17498508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Fekete C, L&#xe9;gr&#xe1;di G, Lechan RM (2003) Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res 985(2):163&#x2013;168</Citation><ArticleIdList><ArticleId IdType="pubmed">12967720</ArticleId><ArticleId IdType="doi">10.1016/S0006-8993(03)03117-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle ME, Egan JM (2001) Glucagon-like peptide-1. Recent Prog Horm Res 56:377&#x2013;399. https://doi.org/10.1210/rp.56.1.377</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/rp.56.1.377</ArticleId><ArticleId IdType="pubmed">11237222</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassil F, Fernagut PO, Bezard E, Meissner WG (2014) Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification? Prog Neurobiol 118:1&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">24582776</ArticleId><ArticleId IdType="doi">10.1016/j.pneurobio.2014.02.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin F, Jiang T, Cadenas E (2013) Metabolic triad in brain aging: mitochondria, insulin/IGF-1 signalling and JNK signalling.</Citation></Reference><Reference><Citation>Saenger S, Holtmann B, Nilges MR, Schroeder S, Hoeflich A, Kletzl H, Spooren W, Ostrowitzki S, Hanania T, Sendtner M et al (2012) Functional improvement in mouse models of familial amyotrophic lateral sclerosis by pegylated insulin-like growth factor i treatment depends on disease severity. Amyotroph Lateral Scler 13:418&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pubmed">22871074</ArticleId><ArticleId IdType="doi">10.3109/17482968.2012.679944</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27(12):2684&#x2013;2690</Citation><ArticleIdList><ArticleId IdType="pubmed">17916769</ArticleId><ArticleId IdType="doi">10.1161/ATVBAHA.107.156257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao CN, Geng YJ, Li F, Yang T, Su DF, Duan JL, Li Y (2011) Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis. Apoptosis 16(11):1118&#x2013;1127</Citation><ArticleIdList><ArticleId IdType="pubmed">21785846</ArticleId><ArticleId IdType="doi">10.1007/s10495-011-0634-9</ArticleId></ArticleIdList></Reference><Reference><Citation>McMorris FA, McKinnon RD (1996) Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol 6(3):313&#x2013;329</Citation><ArticleIdList><ArticleId IdType="pubmed">8864287</ArticleId><ArticleId IdType="doi">10.1111/j.1750-3639.1996.tb00858.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinberg YY, Dibbern ME, Levasseur VA, Kraig RP (2013) Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-&#x3b1; responses to spreading depression. J Neurochem 126(5):662&#x2013;672</Citation><ArticleIdList><ArticleId IdType="pubmed">23586526</ArticleId><ArticleId IdType="pmc">3752330</ArticleId><ArticleId IdType="doi">10.1111/jnc.12267</ArticleId></ArticleIdList></Reference><Reference><Citation>Labandeira-Garcia JL, Costa-Besada MA, Labandeira CM, Villar-Cheda B, Rodr&#xed;guez-Perez AI (2017) Insulin-like growth factor-1 and neuroinflammation. Front Aging Neurosci 9:365</Citation><ArticleIdList><ArticleId IdType="pubmed">29163145</ArticleId><ArticleId IdType="pmc">5675852</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2017.00365</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Haidet AM, Yang W, Passini MA, Hester M, Clarke J, Roskelley EM, Treleaven CM, Rizo L, Martin H, Kim SH (2008) Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol Ther 16(6):1056&#x2013;1064</Citation><ArticleIdList><ArticleId IdType="pubmed">18388910</ArticleId><ArticleId IdType="doi">10.1038/mt.2008.60</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam M, Yadav RK, Minj E, Tiwari A, Mehan S (2020) Exploring molecular approaches in amyotrophic lateral sclerosis: drug targets from clinical and pre-clinical findings. Curr Mol Pharmacol 13:1. https://doi.org/10.2174/1566524020666200427214356</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524020666200427214356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Wu TH, Budde MD, Lee JM, Song SK (2011) Noninvasive detection of brainstem and spinal cord axonal degeneration in an amyotrophic lateral sclerosis mouse model. NMR Biomed 24(2):163&#x2013;169</Citation><ArticleIdList><ArticleId IdType="pubmed">21344532</ArticleId><ArticleId IdType="doi">10.1002/nbm.1567</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RP, Jones AR, Sproviero W, Shatunov A, Shaw PJ, Leigh PN, Young CA, Shaw CE, Mora G, Mandrioli J, Borghero G (2017) Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. Neurology 89(18):1915&#x2013;1922</Citation><ArticleIdList><ArticleId IdType="pubmed">28978660</ArticleId><ArticleId IdType="pmc">5664299</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000004606</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, Rao M (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29(9):824&#x2013;828</Citation><ArticleIdList><ArticleId IdType="pubmed">21832997</ArticleId><ArticleId IdType="pmc">3170425</ArticleId><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakavayev S, Chetrit N, Zvagelsky T, Mansour R, Vyazmensky M, Barak Z, Israelson A, Engel S (2019) Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H<sub>2</sub>O<sub>2</sub> via cysteine-dependent redox short-circuit. Sci Rep 9(1):10826. https://doi.org/10.1038/s41598-019-47326-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47326-x</ArticleId><ArticleId IdType="pubmed">31346243</ArticleId><ArticleId IdType="pmc">6658568</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. The Lancet Neurology 17(1):94&#x2013;102. https://doi.org/10.1016/S1474-4422(17)30401-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mazzini L, Mora G (2020 May 1) Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology. 167:107986. https://doi.org/10.1016/j.neuropharm.2020.107986</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2020.107986</ArticleId><ArticleId IdType="pubmed">32062193</ArticleId></ArticleIdList></Reference><Reference><Citation>Minj E, Yadav RK, Mehan S (2021) Targeting abnormal Nrf2/HO-1 signaling in amyotrophic lateral sclerosis: current Insights on drug targets and influences on neurological disorders. Curr Mol Med 21:1. https://doi.org/10.2174/1566524021666210111104920</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524021666210111104920</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14(3):457&#x2013;487</Citation><ArticleIdList><ArticleId IdType="pubmed">20070435</ArticleId><ArticleId IdType="pmc">3823450</ArticleId></ArticleIdList></Reference><Reference><Citation>Statland JM, Barohn RJ, McVey AL, Katz JS, Dimachkie MM (2015) Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis. Neurol Clin 33(4):735&#x2013;748</Citation><ArticleIdList><ArticleId IdType="pubmed">26515618</ArticleId><ArticleId IdType="pmc">4629510</ArticleId><ArticleId IdType="doi">10.1016/j.ncl.2015.07.006</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Swash M (2016) Lower motor neuron dysfunction in ALS. Clin Neurophysiol 127(7):2670&#x2013;2681</Citation><ArticleIdList><ArticleId IdType="pubmed">27117334</ArticleId><ArticleId IdType="doi">10.1016/j.clinph.2016.03.024</ArticleId><ArticleId IdType="pmc">27117334</ArticleId></ArticleIdList></Reference><Reference><Citation>Bersano E, Sarnelli MF, Solara V, Iazzolino B, Peotta L, De Marchi F, Facchin A, Moglia C, Canosa A, Calvo A, Chi&#xf2; A, Mazzini L (2020 Aug) Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotroph Lateral Scler Frontotemporal Degener 21(5-6):373&#x2013;379. https://doi.org/10.1080/21678421.2020.1771732</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1771732</ArticleId><ArticleId IdType="pubmed">32484726</ArticleId><ArticleId IdType="pmc">32484726</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chi&#xf2; A (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168&#x2013;173. https://doi.org/10.1136/jnnp-2013-307223</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId><ArticleId IdType="pmc">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Weber M (2001) The motor cortex and amyotrophic lateral sclerosis. Muscle &amp; Nerve: Official Journal of the American Association of Electrodiagnostic Medicine 24(4):564&#x2013;573</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.1042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, Unrath A, Huppertz HJ, Lul&#xe9; D, Ethofer T, Sperfeld AD, Ludolph AC (2005) Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler 6(4):213&#x2013;220</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510038538</ArticleId></ArticleIdList></Reference><Reference><Citation>Nodera H, Takamatsu N, Shimatani Y, Mori A, Sato K, Oda M, Terasawa Y, Izumi Y, Kaji R (2014) Thinning of cervical nerve roots and peripheral nerves in ALS as measured by sonography. Clin Neurophysiol 125(9):1906&#x2013;1911</Citation><ArticleIdList><ArticleId IdType="pubmed">24657162</ArticleId><ArticleId IdType="doi">10.1016/j.clinph.2014.01.033</ArticleId><ArticleId IdType="pmc">24657162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanyu N, Oguchi K, Yanagisawa N, Tsukagoshi H (1982) Degeneration and regeneration of ventral root motor fibers in amyotrophic lateral sclerosis: morphometric studies of cervical ventral roots. J Neurol Sci 55(1):99&#x2013;115</Citation><ArticleIdList><ArticleId IdType="pubmed">7108564</ArticleId><ArticleId IdType="doi">10.1016/0022-510X(82)90173-3</ArticleId><ArticleId IdType="pmc">7108564</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei K, McKee AC, Kowall NW (1993) Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol 86(1):55&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pubmed">8396837</ArticleId><ArticleId IdType="doi">10.1007/BF00454899</ArticleId><ArticleId IdType="pmc">8396837</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, Roberts CJ, Miller KR, Ransohoff RM, Trojanowski JQ, Lee VMY (2018) Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci 21(3):329&#x2013;340</Citation><ArticleIdList><ArticleId IdType="pubmed">29463850</ArticleId><ArticleId IdType="pmc">5857237</ArticleId><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo VC, Gluckman PD, Feldman EL, Werther GA (2005) The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 26(7):916&#x2013;943. https://doi.org/10.1210/er.2004-0024</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2004-0024</ArticleId><ArticleId IdType="pubmed">16131630</ArticleId><ArticleId IdType="pmc">16131630</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller AP, Fernandez AM, Haas C, Zimmer E, Portela LV, Torres-Aleman I (2012) Reduced brain insulin-like growth factor I function during aging. Mol Cell Neurosci 49(1):9&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">21807098</ArticleId><ArticleId IdType="doi">10.1016/j.mcn.2011.07.008</ArticleId><ArticleId IdType="pmc">21807098</ArticleId></ArticleIdList></Reference><Reference><Citation>Quesada A, Lee BY, Micevych PE (2008) PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson&#x2019;s disease. Dev Neurobiol 68:632&#x2013;644</Citation><ArticleIdList><ArticleId IdType="pubmed">18278798</ArticleId><ArticleId IdType="pmc">2667142</ArticleId><ArticleId IdType="doi">10.1002/dneu.20609</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamurthi R, Stott S, Maingay M, Faull RL, McCarthy D, Gluckman P, Guan J (2004) N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. Neuroreport 15:1601&#x2013;1604</Citation><ArticleIdList><ArticleId IdType="pubmed">15232291</ArticleId><ArticleId IdType="doi">10.1097/01.wnr.0000127461.15985.07</ArticleId><ArticleId IdType="pmc">15232291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye P, Li L, Richards RG, DiAugustine RP, D&#x2019;Ercole AJ (2002 Jul 15) Myelination is altered in insulin-like growth factor I null mutant mice. J Neurosci 22(14):6041&#x2013;6051. https://doi.org/10.1523/JNEUROSCI.22-14-06041.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-14-06041.2002</ArticleId><ArticleId IdType="pubmed">12122065</ArticleId><ArticleId IdType="pmc">6757955</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Ye P, O&#x2019;Kusky JR, D&#x2019;Ercole AJ (2009 Oct) Type 1 insulin-like growth factor receptor signaling is essential for the development of the hippocampal formation and dentate gyrus. J Neurosci Res 87(13):2821&#x2013;2832. https://doi.org/10.1002/jnr.22129</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22129</ArticleId><ArticleId IdType="pubmed">19437543</ArticleId><ArticleId IdType="pmc">19437543</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzenberger M, Dupont J, Ducos B, Leneuve P, G&#xe9;lo&#xeb;n A, Even PC, Cervera P, Le Bouc Y (2003 Jan 9) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 421(6919):182&#x2013;187. https://doi.org/10.1038/nature01298</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01298</ArticleId><ArticleId IdType="pubmed">12483226</ArticleId><ArticleId IdType="pmc">12483226</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F (1995 Apr) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14(4):717&#x2013;730. https://doi.org/10.1016/0896-6273(95)90216-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90216-3</ArticleId><ArticleId IdType="pubmed">7718235</ArticleId><ArticleId IdType="pmc">7718235</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CM, Mervis RF, Niu SL, Salem N Jr, Witters LA, Tseng V, Reinhardt R, Bondy CA (2003 Jul 1) Insulin-like growth factor 1 is essential for normal dendritic growth. J Neurosci Res 73(1):1&#x2013;9. https://doi.org/10.1002/jnr.10634</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10634</ArticleId><ArticleId IdType="pubmed">12815703</ArticleId><ArticleId IdType="pmc">12815703</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeger M, Popken G, Zhang J, Xuan S, Lu QR, Schwab MH, Klaus-Armin Nave, Rowitch D, D&#x2019;Ercole AJ, Ye P (2007). Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal &lt;em&gt;in vivo&lt;/em&gt; oligodendrocyte development and myelination 55(4), 400&#x2013;411. doi:10.1002/glia.20469</Citation></Reference><Reference><Citation>Ye P, Carson J, D&#x2019;Ercole AJ (1995) In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 15(11):7344&#x2013;7356. https://doi.org/10.1523/JNEUROSCI.15-11-07344.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.15-11-07344.1995</ArticleId><ArticleId IdType="pubmed">7472488</ArticleId><ArticleId IdType="pmc">6578047</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas T, Faivre E, H&#xf6;lscher C (2009 Dec 14) Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer&#x2019;s disease. Behav Brain Res 205(1):265&#x2013;271. https://doi.org/10.1016/j.bbr.2009.06.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2009.06.035</ArticleId><ArticleId IdType="pubmed">19573562</ArticleId></ArticleIdList></Reference><Reference><Citation>During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 9(9):1173&#x2013;1179</Citation><ArticleIdList><ArticleId IdType="pubmed">12925848</ArticleId><ArticleId IdType="doi">10.1038/nm919</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka J-I, Suzuki E, Kondo Y (2000) Endogenous GLP-1 is involved in &#x3b2;-amyloid protein-induced memory impairment and hippocampal neuronal death in rats. Brain Res 878(1-2):194&#x2013;198. https://doi.org/10.1016/s0006-8993(00)02741-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-8993(00)02741-4</ArticleId><ArticleId IdType="pubmed">10996151</ArticleId></ArticleIdList></Reference><Reference><Citation>Knauf C, Cani PD, Kim DH, Iglesias MA, Chabo C, Waget A, Colom A, Rastrelli S, Delzenne NM, Drucker DJ, Seeley RJ, Burcelin R (2008 Oct) Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. Diabetes. 57(10):2603&#x2013;2612. https://doi.org/10.2337/db07-1788</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-1788</ArticleId><ArticleId IdType="pubmed">18519802</ArticleId><ArticleId IdType="pmc">2551668</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval DA, Bagnol D, Woods SC, D&#x2019;Alessio DA, Seeley RJ (2008 Aug) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes. 57(8):2046&#x2013;2054. https://doi.org/10.2337/db07-1824</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-1824</ArticleId><ArticleId IdType="pubmed">18487451</ArticleId><ArticleId IdType="pmc">2494674</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH (2009 Jan 27) GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A 106(4):1285&#x2013;1290. https://doi.org/10.1073/pnas.0806720106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806720106</ArticleId><ArticleId IdType="pubmed">19164583</ArticleId><ArticleId IdType="pmc">2633544</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaman L, Comer J (2000). Antagonism of central glucagon-like peptide-1 receptors enhances lipopolysaccharide-induced fever 85(1-3), 101. doi:10.1016/s1566-0702(00)00227-7</Citation></Reference><Reference><Citation>Humbert S, Bryson EA, Cordeli&#xe8;res FP, Connors NC, Datta SR, Finkbeiner S, Greenberg ME, Saudou F (2002) The IGF-1/Akt pathway is neuroprotective in Huntington&#x2019;s disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2(6):831&#x2013;837</Citation><ArticleIdList><ArticleId IdType="pubmed">12062094</ArticleId><ArticleId IdType="doi">10.1016/S1534-5807(02)00188-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel GR, Leon ML, Uriarte M, Reggiani PC, Goya RG (2017) Therapeutic potential of IGF-1 on hippocampal neurogenesis and function during aging. Neurogenesis (Austin) 4:e1259709</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23262133.2016.1259709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilak MM, Kuncl RW (2001) Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons. Neuroreport 12(11):2531&#x2013;2535</Citation><ArticleIdList><ArticleId IdType="pubmed">11496143</ArticleId><ArticleId IdType="doi">10.1097/00001756-200108080-00048</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry T, Greig NH (2005) Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer&#x2019;s disease. Curr Alzheimer Res 2:377&#x2013;385</Citation><ArticleIdList><ArticleId IdType="pubmed">15974903</ArticleId><ArticleId IdType="doi">10.2174/1567205054367892</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;lscher C (2018) Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer&#x2019;s and Parkinson&#x2019;s disease models. Neuropharmacology 136(Pt B):251&#x2013;259. https://doi.org/10.1016/j.neuropharm.2018.01.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.01.040</ArticleId><ArticleId IdType="pubmed">29402504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JL, Chen WY, Chen YP, Kuo CY, Chen SD (2016) Activation of GLP-1 receptor enhances neuronal base excision repair via PI3K-AKT-induced expression of apurinic/apyrimidinic endonuclease 1. Theranostics 6(12):2015</Citation><ArticleIdList><ArticleId IdType="pubmed">27698937</ArticleId><ArticleId IdType="pmc">5039677</ArticleId><ArticleId IdType="doi">10.7150/thno.15993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobu&#x15b; A, Machali&#x144;ski B (2016) Trophic factors in the therapeutic challenge against ALS: current research directions. Update on Amyotrophic Lateral Sclerosis, 213.</Citation></Reference><Reference><Citation>Adem A, Ekblom J, Gillberg PG, Jossan SS, H&#xf6;&#xf6;g A, Winblad B, Aquilonius SM, Wang LH, Sara V (1994) Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis. Journal of Neural Transmission/General Section JNT 97(1):73&#x2013;84</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01277964</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu CZ, Auer RN (1994) Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J Cereb Blood Flow Metab 14(2):237&#x2013;242</Citation><ArticleIdList><ArticleId IdType="pubmed">8113320</ArticleId><ArticleId IdType="doi">10.1038/jcbfm.1994.30</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo DM, Lapchak PA, Collier B, Chabot JG, Quirion R (1989) Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res 484(1-2):130&#x2013;138</Citation><ArticleIdList><ArticleId IdType="pubmed">2540883</ArticleId><ArticleId IdType="doi">10.1016/0006-8993(89)90355-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona-G&#xf3;mez GP, Chowen JA, Garcia-Segura LM (2000) Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats. J Neurobiol 43(3):269&#x2013;281</Citation><ArticleIdList><ArticleId IdType="pubmed">10842239</ArticleId><ArticleId IdType="doi">10.1002/(SICI)1097-4695(20000605)43:3&lt;269::AID-NEU5&gt;3.0.CO;2-D</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez E, Mart&#xed;nez MD, Roncero I, Chowen JA, Garc&#xed;a-Cuartero B, Gispert JD, Sanz C, V&#xe1;zquez P, Maldonado A, De C&#xe1;ceres J, Desco M (2005) The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 92(4):798&#x2013;806</Citation><ArticleIdList><ArticleId IdType="pubmed">15686481</ArticleId><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02914.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Heppner KM, Kirigiti M, Secher A, Paulsen SJ, Buckingham R, Pyke C, Knudsen LB, Vrang N, Grove KL (2015) Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain. Endocrinology 156(1):255&#x2013;267</Citation><ArticleIdList><ArticleId IdType="pubmed">25380238</ArticleId><ArticleId IdType="doi">10.1210/en.2014-1675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton A, Holscher C (2009) Receptors for the insulin-like peptide GLP-1 are expressed on neurons in the CNS Neuroreport 20: 1161</Citation></Reference><Reference><Citation>Dupont J, Khan J, Qu BH, Metzler P, Helman L, LeRoith D (2001) Insulin and IGF-1 induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: identification by cDNA microarray analysis. Endocrinology 142(11):4969&#x2013;4975</Citation><ArticleIdList><ArticleId IdType="pubmed">11606465</ArticleId><ArticleId IdType="doi">10.1210/endo.142.11.8476</ArticleId></ArticleIdList></Reference><Reference><Citation>Freude S, Leeser U, M&#xfc;ller M, Hettich MM, Udelhoven M, Schilbach K, Tobe K, Kadowaki T, K&#xf6;hler C, Schr&#xf6;der H, Krone W (2008) IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination. J Neurochem 107(4):907&#x2013;917</Citation><ArticleIdList><ArticleId IdType="pubmed">18717815</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan J (2008) Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for ischemic brain injury. Recent patents on CNS drug discovery 3(2):112&#x2013;127</Citation><ArticleIdList><ArticleId IdType="pubmed">18537771</ArticleId><ArticleId IdType="doi">10.2174/157488908784534630</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill BT, Lauritzen HP, Hirshman MF, Smyth G, Goodyear LJ, Kahn CR (2015) Differential role of insulin/IGF-1 receptor signaling in muscle growth and glucose homeostasis. Cell Rep 11(8):1220&#x2013;1235</Citation><ArticleIdList><ArticleId IdType="pubmed">25981038</ArticleId><ArticleId IdType="pmc">4449334</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2015.04.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesik D, De Keyser J, Wilczak N (2008) Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J Mol Neurosci 35(1):81</Citation><ArticleIdList><ArticleId IdType="pubmed">18299999</ArticleId><ArticleId IdType="doi">10.1007/s12031-008-9041-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SE, Dantzer R, Kelley KW, McCusker RH (2011) Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflammation 8(1):1&#x2013;14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I (2002) Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8:1390&#x2013;1397</Citation><ArticleIdList><ArticleId IdType="pubmed">12415260</ArticleId><ArticleId IdType="doi">10.1038/nm1202-793</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH (2002) Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J Pharmacol Exp Ther 302(3):881&#x2013;888</Citation><ArticleIdList><ArticleId IdType="pubmed">12183643</ArticleId><ArticleId IdType="doi">10.1124/jpet.102.037481</ArticleId></ArticleIdList></Reference><Reference><Citation>Brubaker PL, Drucker DJ (2004) Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145(6):2653&#x2013;2659</Citation><ArticleIdList><ArticleId IdType="pubmed">15044356</ArticleId><ArticleId IdType="doi">10.1210/en.2004-0015</ArticleId></ArticleIdList></Reference><Reference><Citation>Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R (2002) Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143(11):4397&#x2013;4408</Citation><ArticleIdList><ArticleId IdType="pubmed">12399437</ArticleId><ArticleId IdType="doi">10.1210/en.2002-220405</ArticleId></ArticleIdList></Reference><Reference><Citation>Green BD, Mooney MH, Gault VA, Irwin N, Bailey CJ, Harriott P, Greer B, O&#x2019;Harte FP, Flatt PR (2004 Mar) N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity. J Endocrinol 180(3):379&#x2013;388. https://doi.org/10.1677/joe.0.1800379</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/joe.0.1800379</ArticleId><ArticleId IdType="pubmed">15012592</ArticleId></ArticleIdList></Reference><Reference><Citation>Acuna-Goycolea C, van den Pol A (2004) Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 24:8141&#x2013;8152</Citation><ArticleIdList><ArticleId IdType="pubmed">15371515</ArticleId><ArticleId IdType="pmc">6729787</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.1607-04.2004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman CP, Perry T, Furukawa K, Grieg NH, Egan JM, Mattson MP (2003) Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons. J Neurochem 87(5):1137&#x2013;1144</Citation><ArticleIdList><ArticleId IdType="pubmed">14622093</ArticleId><ArticleId IdType="doi">10.1046/j.1471-4159.2003.02073.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O&#x2019;Regan JP, Deng HX, Rahmani Z (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId><ArticleId IdType="pmc">8446170</ArticleId><ArticleId IdType="doi">10.1038/362059a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovic A, Leigh PN (1996) Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 61(6):565</Citation><ArticleIdList><ArticleId IdType="pubmed">8971099</ArticleId><ArticleId IdType="pmc">486646</ArticleId><ArticleId IdType="doi">10.1136/jnnp.61.6.565</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenger S, Holtmann B, Nilges MR, Schroeder S, Hoeflich A, Kletzl H, Spooren W, Ostrowitzki S, Hanania T, Sendtner M, Metzger F (2012) Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity. Amyotroph Lateral Scler 13(5):418&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pubmed">22871074</ArticleId><ArticleId IdType="doi">10.3109/17482968.2012.679944</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz CK, Federici T, Yang J, Backus C, Oh SS, Teng Q, Carlton E, Bishop KM, Gasmi M, Bartus RT, Feldman EL (2009) Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS. Neurobiol Dis 33(3):473&#x2013;481</Citation><ArticleIdList><ArticleId IdType="pubmed">19135533</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2008.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar BK, Llad&#xf3; J, Sherkat N, Rothstein JD, Gage FH (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301(5634):839&#x2013;842</Citation><ArticleIdList><ArticleId IdType="pubmed">12907804</ArticleId><ArticleId IdType="doi">10.1126/science.1086137</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, Molinaro M, Rosenthal N, Musar&#xf2; A (2005) Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 168(2):193&#x2013;199</Citation><ArticleIdList><ArticleId IdType="pubmed">15657392</ArticleId><ArticleId IdType="pmc">2171577</ArticleId><ArticleId IdType="doi">10.1083/jcb.200407021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, Haenggeli C, Gasmi M, Bishop KM, Bartus RT, Maragakis NJ, Rothstein JD (2007) Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Res 1185:256&#x2013;265</Citation><ArticleIdList><ArticleId IdType="pubmed">17963733</ArticleId><ArticleId IdType="pmc">2265207</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2007.09.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano I, Ilieva H, Shiote M, Murakami T, Yokoyama M, Shoji M, Abe K (2005) Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis. J Neurol Sci 235(1-2):61&#x2013;68</Citation><ArticleIdList><ArticleId IdType="pubmed">15990113</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2005.04.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S, Thau N, Schwabe K, Dengler R, Schambach A, Hass R, Petri S (2012) Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 9(3):107&#x2013;120</Citation><ArticleIdList><ArticleId IdType="pubmed">22122965</ArticleId><ArticleId IdType="doi">10.1159/000331327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Knippenberg S, Thau N, Ragancokova D, K&#xf6;rner S, Huang D, Dengler R, D&#xf6;hler K, Petri S (2013) Therapeutic potential of N-acetyl-glucagon-like peptide-1 in primary motor neuron cultures derived from non-transgenic and SOD1-G93A ALS mice. Cell Mol Neurobiol 33(3):347&#x2013;357</Citation><ArticleIdList><ArticleId IdType="pubmed">23271639</ArticleId><ArticleId IdType="doi">10.1007/s10571-012-9900-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaki H, Tamatani M, Mitsuda N, Namikawa K, Kiyama H, Miyake SI, Tohyama M (1999) Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J Neurochem 73:2037&#x2013;2046</Citation><ArticleIdList><ArticleId IdType="pubmed">10537063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Huang L, Zhang M, Sun S, Wu Y (2010) Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta. Toxicology 271(1-2):5&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">20064577</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2010.01.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu H, Xu C, Zhang W, Liu Q, Rondard P, Pin JP, Liu J (2010) GABAB receptor activation protects neurons from apoptosis via IGF-1 receptor transactivation. J Neurosci 30(2):749&#x2013;759</Citation><ArticleIdList><ArticleId IdType="pubmed">20071540</ArticleId><ArticleId IdType="pmc">6633015</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.2343-09.2010</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawada WM, Kirschman DL, Cohen JJ, Heidenreich KA, Freed CR (1996) Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp Neurol 140(1):60&#x2013;67</Citation><ArticleIdList><ArticleId IdType="pubmed">8682180</ArticleId><ArticleId IdType="doi">10.1006/exnr.1996.0115</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chigurupati S, Holloway HW, Mughal M, Tweedie D, Bruestle DA, Mattson MP, Wang Y, Harvey BK, Ray B, Lahiri DK (2012) Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis. PLoS One 7(2):e32008</Citation><ArticleIdList><ArticleId IdType="pubmed">22384126</ArticleId><ArticleId IdType="pmc">3285661</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0032008</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohiuddin MS, Himeno T, Inoue R, Miura-Yura E, Yamada Y, Nakai-Shimoda H, Asano S, Kato M, Motegi M, Kondo M, Seino Y (2019) Glucagon-like Peptide-1 receptor agonist protects dorsal root ganglion neurons against oxidative insult. J Diabetes Res 2019:1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9426014</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave K-A (2010) Myelination and the trophic support of long axons. Nat Rev Neurosci 11:275&#x2013;283</Citation><ArticleIdList><ArticleId IdType="pubmed">20216548</ArticleId><ArticleId IdType="doi">10.1038/nrn2797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins A, Chandran S, Compston A (2001) A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 36(1):48&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pubmed">11571783</ArticleId><ArticleId IdType="doi">10.1002/glia.1094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye P, D&#x2019;ercole AJ (1999) Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-&#x3b1;-induced injury. Endocrinology 140(7):3063&#x2013;3072</Citation><ArticleIdList><ArticleId IdType="pubmed">10385398</ArticleId><ArticleId IdType="doi">10.1210/endo.140.7.6754</ArticleId></ArticleIdList></Reference><Reference><Citation>Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff M (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70(1):31&#x2013;46</Citation><ArticleIdList><ArticleId IdType="pubmed">1623522</ArticleId><ArticleId IdType="doi">10.1016/0092-8674(92)90531-G</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozell RL, McMorris FA (1991) Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J Neurosci Res 30(2):382&#x2013;390</Citation><ArticleIdList><ArticleId IdType="pubmed">1665869</ArticleId><ArticleId IdType="doi">10.1002/jnr.490300214</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kusky J, Ye P (2012) Neurodevelopmental effects of insulin-like growth factor signaling. Front Neuroendocrinol 33(3):230&#x2013;251</Citation><ArticleIdList><ArticleId IdType="pubmed">22710100</ArticleId><ArticleId IdType="pmc">3677055</ArticleId><ArticleId IdType="doi">10.1016/j.yfrne.2012.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye P, D&#x2019;rcole AJ (2006) Insulin-like growth factor actions during development of neural stem cells and progenitors in the central nervous system. J Neurosci Res 83(1):1&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">16294334</ArticleId><ArticleId IdType="doi">10.1002/jnr.20688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh J, Aimone JB, Kaspar BK, Kuwabara T, Nakashima K, Gage FH (2004) IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J Cell Biol 164(1):111&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pubmed">14709544</ArticleId><ArticleId IdType="pmc">2171962</ArticleId><ArticleId IdType="doi">10.1083/jcb.200308101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gago N, Avellana-Adalid V, Baron-Van Evercooren A, Schumacher M (2003) Control of cell survival and proliferation of postnatal PSA-NCAM+ progenitors. Mol Cell Neurosci 22(2):162&#x2013;178</Citation><ArticleIdList><ArticleId IdType="pubmed">12676527</ArticleId><ArticleId IdType="doi">10.1016/S1044-7431(02)00030-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wlodarczyk A, Holtman IR, Krueger M, Yogev N, Bruttger J, Khorooshi R et al (2017) A novel microglial subset plays a key role in myelinogenesis in developing brain. EMBO J 36:3292&#x2013;3308. https://doi.org/10.15252/embj.201696056</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696056</ArticleId><ArticleId IdType="pubmed">28963396</ArticleId><ArticleId IdType="pmc">5686552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton A, Patterson S, Porter D, Gault VA, Holscher C (2011) Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J Neurosci Res 89(4):481&#x2013;489</Citation><ArticleIdList><ArticleId IdType="pubmed">21312223</ArticleId><ArticleId IdType="doi">10.1002/jnr.22565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramanti V, Grasso S, Tomassoni D, Traini E, Raciti G, Viola M, Li Volti G, Campisi A, Amenta F, Avola R (2015) Effect of growth factors and steroid hormones on heme oxygenase and cyclin d1 expression in primary astroglial cell cultures. J Neurosci Res 93:521&#x2013;529</Citation><ArticleIdList><ArticleId IdType="pubmed">25388553</ArticleId><ArticleId IdType="doi">10.1002/jnr.23506</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawji KS, Mishra MK, Michaels NJ, Rivest S, Stys PK, Yong VW (2016) Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. Brain 139(3):653&#x2013;661</Citation><ArticleIdList><ArticleId IdType="pubmed">26912633</ArticleId><ArticleId IdType="pmc">5839598</ArticleId><ArticleId IdType="doi">10.1093/brain/awv395</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-H&#xe9;bert M, Gowing G, Simard A, Weng YC, Kriz J (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27(10):2596&#x2013;2605</Citation><ArticleIdList><ArticleId IdType="pubmed">17344397</ArticleId><ArticleId IdType="pmc">6672496</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.5360-06.2007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadjar A, Berton O, Guo S, Leneuve P, Dovero S, Diguet E, Tison F, Zhao B, Holzenberger M, Bezard E (2009) IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP. Neurobiol Aging 30(12):2021&#x2013;2030</Citation><ArticleIdList><ArticleId IdType="pubmed">18394756</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.02.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh HS, Zhao ML, Derico L, Choi N, Lee SC (2013) Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J Neuroinflammation 10(1):1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-10-37</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferger AI, Campanelli L, Reimer V, Muth KN, Merdian I, Ludolph AC, Witting A (2010) Effects of mitochondrial dysfunction on the immunological properties of microglia. J Neuroinflammation 7(1):1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-45</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91(2):461&#x2013;553</Citation><ArticleIdList><ArticleId IdType="pubmed">21527731</ArticleId><ArticleId IdType="pmc">21527731</ArticleId><ArticleId IdType="doi">10.1152/physrev.00011.2010</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell SL, Frederick TJ, Krady JK, Vannucci SJ, Wood TL (2002) IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. Glia 39(1):85&#x2013;97</Citation><ArticleIdList><ArticleId IdType="pubmed">12112378</ArticleId><ArticleId IdType="doi">10.1002/glia.10081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Jeon SJ, Cho KS, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH, Choi JW (2018) Activation of glucagon-like peptide-1 receptor promotes neuroprotection in experimental autoimmune encephalomyelitis by reducing neuroinflammatory responses. Mol Neurobiol 55:3007&#x2013;3020</Citation><ArticleIdList><ArticleId IdType="pubmed">28456941</ArticleId><ArticleId IdType="doi">10.1007/s12035-017-0550-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu HY, Tang XQ, Liu H, Mao XF, Wang YX (2018) Both classic Gs-cAMP/PKA/CREB and alternative Gs-cAMP/PKA/p38&#x3b2;/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers. J Neuroimmunol 316:17&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">29249556</ArticleId><ArticleId IdType="doi">10.1016/j.jneuroim.2017.12.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A, Puentes F, Amor S (2015) Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. Int Immunol 27(3):117&#x2013;129</Citation><ArticleIdList><ArticleId IdType="pubmed">25344935</ArticleId><ArticleId IdType="doi">10.1093/intimm/dxu099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensley K, Abdel-Moaty H, Hunter J et al. 2006. Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory in the complete rescue of postnatal motor neurons, Amyotroph Lateral Scler Other Motor</Citation></Reference><Reference><Citation>Parakh S, Spencer DM, Halloran MA, Soo KY, Atkin JD (2013) Redox regulation in amyotrophic lateral sclerosis. Oxidative Med Cell Longev 2013:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/408681</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, Baloh RH, Ravits J, Simpson E, Appel SH, Pestronk A, Goate AM, Miller TM, Cruchaga C, Harms MB (2014 Apr) TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 71(4):449&#x2013;453. https://doi.org/10.1001/jamaneurol.2013.6237</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.6237</ArticleId><ArticleId IdType="pubmed">24535663</ArticleId><ArticleId IdType="pmc">4087113</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, Liao B, Appel SH (2011) Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 134(5):1293&#x2013;1314</Citation><ArticleIdList><ArticleId IdType="pubmed">21596768</ArticleId><ArticleId IdType="pmc">3097891</ArticleId><ArticleId IdType="doi">10.1093/brain/awr074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sta M, Sylva-Steenland RMR, Casula M, De Jong JMBV, Troost D, Aronica E, Baas F (2011) Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Neurobiol Dis 42(3):211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pubmed">21220013</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2011.01.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, Zhao W, Beers DR, Yen AA, Xie W, Henkel JS, Appel SH (2007) Mutant SOD1G93A microglia are more neurotoxic relative to wild-type microglia. J Neurochem 102(6):2008&#x2013;2019</Citation><ArticleIdList><ArticleId IdType="pubmed">17555556</ArticleId><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04677.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow RH (2012) Alzheimer&#x2019;s disease pathologic cascades: who comes first, what drives what. Neurotox Res 22(3):182&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pubmed">21913048</ArticleId><ArticleId IdType="doi">10.1007/s12640-011-9272-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu LY, Ho FM, Shiah SG, Chang Y, Lin WW (2011) Oxidative stress initiates DNA damager MNNG-induced poly (ADP-ribose) polymerase-1-dependent parthanatos cell death. Biochem Pharmacol 81(3):459&#x2013;470</Citation><ArticleIdList><ArticleId IdType="pubmed">21056551</ArticleId><ArticleId IdType="doi">10.1016/j.bcp.2010.10.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, El-Kholy W, Rhodes CJ, Brubaker PL (2005) Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 48(7):1339&#x2013;1349</Citation><ArticleIdList><ArticleId IdType="pubmed">15902400</ArticleId><ArticleId IdType="doi">10.1007/s00125-005-1787-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed JC (1997) Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. In Seminars in hematology (Vol. 34 (4 Suppl 5), 9-19).</Citation></Reference><Reference><Citation>Krajewski S, Mai JK, Krajewska M, Sikorska M, Mossakowski MJ, Reed JC (1995) Upregulation of bax protein levels in neurons following cerebral ischemia. J Neurosci 15(10):6364&#x2013;6376</Citation><ArticleIdList><ArticleId IdType="pubmed">7472401</ArticleId><ArticleId IdType="pmc">6578024</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.15-10-06364.1995</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh M, Johnson EM Jr (1998) Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. Neuron 21(4):695&#x2013;705</Citation><ArticleIdList><ArticleId IdType="pubmed">9808457</ArticleId><ArticleId IdType="doi">10.1016/S0896-6273(00)80587-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wu H, Khardori R, Song Y-H, Lu YW, Geng Y-J (2009) Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis. Biochem Biophys Res Commun 384(2):259&#x2013;264. https://doi.org/10.1016/j.bbrc.2009.04.113</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.04.113</ArticleId><ArticleId IdType="pubmed">19406106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, Park S (2018) IGF-1 protects SH-SY5Y cells against MPP + -induced apoptosis via PI3K/PDK-1/Akt pathway. Endocrine Connections 7(3):443&#x2013;455. https://doi.org/10.1530/ec-17-0350</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ec-17-0350</ArticleId><ArticleId IdType="pubmed">29459421</ArticleId><ArticleId IdType="pmc">5843822</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon G, Kim Y-K, Song J (2019). Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure. Pharmacological Research, 104615. doi: https://doi.org/10.1016/j.phrs.2019.104615</Citation></Reference><Reference><Citation>Garabadu D, Verma J (2019) Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1&#x2013;42)-induced cognitive deficit rats. Neurochem Int 128:39&#x2013;49. https://doi.org/10.1016/j.neuint.2019.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.04.006</ArticleId><ArticleId IdType="pubmed">31004737</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wang F (2017) Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 8:1005</Citation><ArticleIdList><ArticleId IdType="pubmed">28871262</ArticleId><ArticleId IdType="pmc">5567007</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Wang CM, Yang WL, Wang P (2013) Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia. Brain Res 1506:105&#x2013;114</Citation><ArticleIdList><ArticleId IdType="pubmed">23416151</ArticleId><ArticleId IdType="pmc">3615048</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2013.02.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Zhao W, Appel SH (2009) Microglia in ALS: the good, the bad, and the resting. J NeuroImmune Pharmacol 4(4):389&#x2013;398</Citation><ArticleIdList><ArticleId IdType="pubmed">19731042</ArticleId><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Motani A, Forster L, Tull S, Anggard EE, Ferns GA (1996) Insulin-like growth factor-I modulates monocyte adhesion to EAhy 926 endothelial cells. Int J Exp Pathol 77:31&#x2013;35. https://doi.org/10.1046/j.1365-2613.1996.960098.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2613.1996.960098.x</ArticleId><ArticleId IdType="pubmed">8664144</ArticleId><ArticleId IdType="pmc">2691619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluth&#xe9; RM, Kelley KW, Dantzer R (2006) Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav Immun 20:57&#x2013;63. https://doi.org/10.1016/j.bbi.2005.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2005.02.003</ArticleId><ArticleId IdType="pubmed">16364817</ArticleId><ArticleId IdType="pmc">2907139</ArticleId></ArticleIdList></Reference><Reference><Citation>Palin K, Bluth&#xe9; RM, McCusker RH, Moos F, Dantzer R, Kelley KW (2007) TNF&#x3b1;-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I. J Neuroimmunol 187:55&#x2013;60. https://doi.org/10.1016/j.jneuroim.2007.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.04.011</ArticleId><ArticleId IdType="pubmed">17512609</ArticleId><ArticleId IdType="pmc">2915825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellini MJ, Here&#xf1;&#xfa; CB, Goya RG, Garcia-Segura LM (2011) Insulin-like growth factor-I gene delivery to astrocytes reduces their inflammatory response to lipopolysaccharide. J Neuroinflammation 8:21. https://doi.org/10.1186/1742-2094-8-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-21</ArticleId><ArticleId IdType="pubmed">21371294</ArticleId><ArticleId IdType="pmc">3056784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S-S, Feng XB, Zhang BH, Xia ZY, Zhan LY (2020) Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation. Neural Regen Res 15(7):1333&#x2013;1339</Citation><ArticleIdList><ArticleId IdType="pubmed">31960821</ArticleId><ArticleId IdType="pmc">7047783</ArticleId><ArticleId IdType="doi">10.4103/1673-5374.272620</ArticleId></ArticleIdList></Reference><Reference><Citation>Diz-Chaves Y, Toba L, Fandi&#xf1;o J, Gonz&#xe1;lez-Mat&#xed;as LC, Garcia-Segura LM, Mallo F (2018) The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction. J Neuroinflammation 15(1):337</Citation><ArticleIdList><ArticleId IdType="pubmed">30518432</ArticleId><ArticleId IdType="pmc">6282252</ArticleId><ArticleId IdType="doi">10.1186/s12974-018-1370-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DS, Choi HI, Wang Y, Luo Y, Hoffer BJ, Greig NH (2017) A new treatment strategy for Parkinson&#x2019;s disease through the gut&#x2013;brain axis: the glucagon-like peptide-1 receptor pathway. Cell Transplant 26(9):1560&#x2013;1571</Citation><ArticleIdList><ArticleId IdType="pubmed">29113464</ArticleId><ArticleId IdType="pmc">5680957</ArticleId><ArticleId IdType="doi">10.1177/0963689717721234</ArticleId></ArticleIdList></Reference><Reference><Citation>Bristol LA, Rothstein JD (1996) Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 39(5):676&#x2013;679</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390519</ArticleId></ArticleIdList></Reference><Reference><Citation>Olloquequi J, Cornejo-C&#xf3;rdova E, Verdaguer E, Soriano FX, Binvignat O, Auladell C, Camins A (2018) Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: therapeutic implications. J Psychopharmacol 32(3):265&#x2013;275</Citation><ArticleIdList><ArticleId IdType="pubmed">29444621</ArticleId><ArticleId IdType="doi">10.1177/0269881118754680</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J, Van Den Bosch L, Keller BU (2010) Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47(2):165&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pubmed">20116097</ArticleId><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pmc">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang W, Li D, Li M, Wang P, Wen J, Liang M, Su B, Yin Y (2014) IGF-1 Alleviates NMDA-induced excitotoxicity in cultured hippocampal neurons against autophagy via the NR2B/PI3K-AKT-mTOR pathway. J Cell Physiol 229(11):1618&#x2013;1629. https://doi.org/10.1002/jcp.24607</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24607</ArticleId><ArticleId IdType="pubmed">24604717</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Sun W, Han S, Li J, Ding S, Wang W, Yin Y (2016) IGF-1-involved negative feedback of NR2B NMDA subunits protects cultured hippocampal neurons against NMDA-induced excitotoxicity. Mol Neurobiol 54(1):684&#x2013;696. https://doi.org/10.1007/s12035-015-9647-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9647-7</ArticleId><ArticleId IdType="pubmed">26758454</ArticleId><ArticleId IdType="pmc">26758454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ness JK, Wood TL (2002) Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis. Mol Cell Neurosci 20(3):476&#x2013;488</Citation><ArticleIdList><ArticleId IdType="pubmed">12139923</ArticleId><ArticleId IdType="doi">10.1006/mcne.2002.1149</ArticleId><ArticleId IdType="pmc">12139923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ness JK, Scaduto RC Jr, Wood TL (2004) IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors. Glia 46(2):183&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pubmed">15042585</ArticleId><ArticleId IdType="doi">10.1002/glia.10360</ArticleId><ArticleId IdType="pmc">15042585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman CP, Perry TA, Furukawa K, Grieg NH, Egan JM, Mattson MP (2003). Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons. 87(5), 1137&#x2013;1144. doi:10.1046/j.1471-4159.2003.02073.x</Citation></Reference><Reference><Citation>Alam MM, Minj E, Yadav RK, Mehan S (2020) Neuroprotective potential of adenyl cyclase/cAMP/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats. Current Bioactive Compounds 16:1. https://doi.org/10.2174/1573407216999200723113054</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573407216999200723113054</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, Van Den Berg LH (2017) Amyotrophic lateral sclerosis. Nature reviews Disease primers 3(1):1&#x2013;19</Citation></Reference><Reference><Citation>D&#x2019;Amico E, Factor-Litvak P, Santella RM, Mitsumoto H (2013) Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med 65:509&#x2013;527</Citation><ArticleIdList><ArticleId IdType="pubmed">23797033</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L, Modena M, Gerfo AL, Ricci G, Ienco EC, Ryskalin L, Fornai F, Siciliano G (2017) Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis. Arch Ital Biol 155(4):131&#x2013;141</Citation><ArticleIdList><ArticleId IdType="pubmed">29405030</ArticleId><ArticleId IdType="pmc">29405030</ArticleId></ArticleIdList></Reference><Reference><Citation>Genis L, D&#xe1;vila D, Fernandez S, Pozo-Rodrig&#xe1;lvarez A, Mart&#xed;nez-Murillo R, Torres-Aleman I (2014) Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury. F1000Research, 3.</Citation></Reference><Reference><Citation>D&#xe1;vila D, Torres-Aleman I (2008) Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. Mol Biol Cell 19(5):2014&#x2013;2025. https://doi.org/10.1091/mbc.e07-08-0811</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e07-08-0811</ArticleId><ArticleId IdType="pubmed">18287535</ArticleId><ArticleId IdType="pmc">2366852</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte AI, Santos P, Oliveira CR, Santos MS, Rego AC (2008) Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3&#x3b2; signaling pathways and changes in protein expression. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1783(6):994&#x2013;1002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2008.02.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooten MW (1999) Function for NF-kB in neuronal survival: regulation by atypical protein kinase C. J Neurosci Res 58(5):607&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">10561688</ArticleId><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19991201)58:5&lt;607::AID-JNR1&gt;3.0.CO;2-M</ArticleId><ArticleId IdType="pmc">10561688</ArticleId></ArticleIdList></Reference><Reference><Citation>Carro E, Trejo JL, Gerber A, Loetscher H, Torrado J, Metzger F, Torres-Aleman I (2006) Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol Aging 27:1250&#x2013;1257</Citation><ArticleIdList><ArticleId IdType="pubmed">16183170</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2005.06.015</ArticleId><ArticleId IdType="pmc">16183170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, Xu H (2001) Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21:2561&#x2013;2570</Citation><ArticleIdList><ArticleId IdType="pubmed">11306609</ArticleId><ArticleId IdType="pmc">6762523</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.21-08-02561.2001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung HY, Lee EK, Choi YJ, Kim JM, Kim DH, Zou Y, Kim CH, Lee J, Kim HS, Kim ND, Jung JH (2011) Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res 90(7):830&#x2013;840</Citation><ArticleIdList><ArticleId IdType="pubmed">21447699</ArticleId><ArticleId IdType="doi">10.1177/0022034510387794</ArticleId><ArticleId IdType="pmc">21447699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao SY (2009) Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors. Biochem Biophys Res Commun 385:434&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pubmed">19470380</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2009.05.089</ArticleId><ArticleId IdType="pmc">19470380</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P (2000) N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 859:286&#x2013;292</Citation><ArticleIdList><ArticleId IdType="pubmed">10719076</ArticleId><ArticleId IdType="doi">10.1016/S0006-8993(00)01988-0</ArticleId><ArticleId IdType="pmc">10719076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert AD, Beres AJ, Barber AE, Svendsen CN (2008) Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson&#x2019;s disease. Exp Neurol 209:213&#x2013;223</Citation><ArticleIdList><ArticleId IdType="pubmed">18061591</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2007.09.022</ArticleId><ArticleId IdType="pmc">18061591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Yang HJ, Xia YY, Feng ZW (2010) Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3beta/JNK signaling. Apoptosis 15(12):1470&#x2013;1479. https://doi.org/10.1007/s10495-010-0547-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-010-0547-z</ArticleId><ArticleId IdType="pubmed">20963499</ArticleId><ArticleId IdType="pmc">20963499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro MJDC (2014) Oxidative stress in Huntington&#x2019;s disease knock-in striatal cells (Doctoral dissertation).</Citation></Reference><Reference><Citation>Bozdagi O, Tavassoli T, Buxbaum JD (2013 Apr 27) Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay. Mol Autism 4(1):9. https://doi.org/10.1186/2040-2392-4-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2040-2392-4-9</ArticleId><ArticleId IdType="pubmed">23621888</ArticleId><ArticleId IdType="pmc">3649942</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Quigley L, Yao DL, Hudson LD, Brenner M, Zhang BJ, Brocke S, McFarland H, Webster HD (1998) Chronic relapsing experimental autoimmune encephalomyelitis: effects of insulin-like growth factor-I treatment on clinical deficits, lesion severity, glial responses, and blood brain barrier defects. J Neuropathol Exp Neurol 57(5):426&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pubmed">9596413</ArticleId><ArticleId IdType="doi">10.1097/00005072-199805000-00006</ArticleId><ArticleId IdType="pmc">9596413</ArticleId></ArticleIdList></Reference><Reference><Citation>McClean PL, Parthsarathy V, Faivre E, H&#xf6;lscher C (2011 Apr 27) The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer&#x2019;s disease. J Neurosci 31(17):6587&#x2013;6594. https://doi.org/10.1523/JNEUROSCI.0529-11.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0529-11.2011</ArticleId><ArticleId IdType="pubmed">21525299</ArticleId><ArticleId IdType="pmc">6622662</ArticleId></ArticleIdList></Reference><Reference><Citation>Teramoto S, Miyamoto N, Yatomi K, Tanaka Y, Oishi H, Arai H, Hattori N, Urabe T (2011) Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia. J Cereb Blood Flow Metab 31(8):1696&#x2013;1705</Citation><ArticleIdList><ArticleId IdType="pubmed">21487412</ArticleId><ArticleId IdType="pmc">3170947</ArticleId><ArticleId IdType="doi">10.1038/jcbfm.2011.51</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry T, Holloway HW, Weerasuriya A, Mouton PR, Duffy K, Mattison JA, Greig NH (2007) Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp Neurol 203(2):293&#x2013;301</Citation><ArticleIdList><ArticleId IdType="pubmed">17125767</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2006.09.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Niikura T, Hashimoto Y, Okamoto T, Abe Y, Yasukawa T, Kawasumi M, Hiraki T, Kita Y, Terashita K, Kouyama K, Nishimoto I (2001) Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer&#x2019;s V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J Neurosci 21(6):1902&#x2013;1910. https://doi.org/10.1523/jneurosci.21-06-01902.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.21-06-01902.2001</ArticleId><ArticleId IdType="pubmed">11245675</ArticleId><ArticleId IdType="pmc">6762606</ArticleId></ArticleIdList></Reference><Reference><Citation>Offen D, Shtaif B, Hadad D, Weizman A, Melamed E, Gil-Ad I (2001) Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson&#x2019;s disease. Neurosci Lett 316:129&#x2013;132. https://doi.org/10.1016/s0304-3940(01)02344-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0304-3940(01)02344-8</ArticleId><ArticleId IdType="pubmed">11744219</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsarathy V, Holscher C (2011) The novel GLP1 analogue, liraglutide, reduces inflammation in a mouse model of brain tissue injury. In Washington, DC: Society for Neuroscience Annual Meeting.</Citation></Reference><Reference><Citation>Qin Z, Sun Z, Huang J, Hu Y, Wu Z, Mei B (2008) Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-&#x3b2; peptide (1&#x2013;42). Neurosci Lett 444(3):217&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pubmed">18760331</ArticleId><ArticleId IdType="doi">10.1016/j.neulet.2008.08.047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T, Du X, Pick JE, Sui G, Brownlee M, Klann E (2012) Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer&#x2019;s disease model mice. J Neurosci 32(40):13701&#x2013;13708. https://doi.org/10.1523/jneurosci.2107-12.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.2107-12.2012</ArticleId><ArticleId IdType="pubmed">23035082</ArticleId><ArticleId IdType="pmc">3475870</ArticleId></ArticleIdList></Reference><Reference><Citation>Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer&#x2019;s disease&#x2013;associated A&#x3b2; oligomers. J Clin Invest 122(4):1339&#x2013;1353</Citation><ArticleIdList><ArticleId IdType="pubmed">22476196</ArticleId><ArticleId IdType="pmc">3314445</ArticleId><ArticleId IdType="doi">10.1172/JCI57256</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Duffy KB, Ottinger MA, Ray B, Bailey JA, Holloway HW, Tweedie D, Perry T, Mattson MP, Kapogiannis D, Sambamurti K (2010) GLP-1 receptor stimulation reduces amyloid-&#x3b2; peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer&#x2019;s disease. J Alzheimers Dis 19(4):1205&#x2013;1219</Citation><ArticleIdList><ArticleId IdType="pubmed">20308787</ArticleId><ArticleId IdType="pmc">2948479</ArticleId><ArticleId IdType="doi">10.3233/JAD-2010-1314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Moon M, Park S (2009 Sep 1) Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson&#x2019;s disease. J Endocrinol 202(3):431&#x2013;439</Citation><ArticleIdList><ArticleId IdType="pubmed">19570816</ArticleId><ArticleId IdType="doi">10.1677/JOE-09-0132</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkavyi A, Abuirmeileh A, Lever R, Kingsbury AE, Biggs CS, Whitton PS (2008) Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson&#x2019;s disease. J Neuroinflammation 5(1):1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-5-19</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang W, Li D, Li M, Wang P, Wen J, Liang M, Su B, Yin Y (2014 Nov) IGF-1 alleviates NMDA-induced excitotoxicity in cultured hippocampal neurons against autophagy via the NR2B/PI3K-AKT-mTOR pathway. J Cell Physiol 229(11):1618&#x2013;1629. https://doi.org/10.1002/jcp.24607</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24607</ArticleId><ArticleId IdType="pubmed">24604717</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico M, Di Filippo C, Marfella R, Abbatecola AM, Ferraraccio F, Rossi F et al (2010) Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer&#x2019;s prone mice. Exp Gerontol 45:202&#x2013;207</Citation><ArticleIdList><ArticleId IdType="pubmed">20005285</ArticleId><ArticleId IdType="doi">10.1016/j.exger.2009.12.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroni P (1993 Aug 27) Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system. Ann N Y Acad Sci 692:209&#x2013;222. https://doi.org/10.1111/j.1749-6632.1993.tb26219.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1993.tb26219.x</ArticleId><ArticleId IdType="pubmed">8215024</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroni P, Grandes P (1990 Apr) Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol 110(4):1307&#x2013;1317. https://doi.org/10.1083/jcb.110.4.1307</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.110.4.1307</ArticleId><ArticleId IdType="pubmed">2157718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanta&#xef; D, Akaaboune M, Lagord C, Murawsky M, Houenou LJ, Festoff BW, Vaught JL, Rieger F, Blondet B (1995 May) Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease. J Neurol Sci 129(Suppl):122&#x2013;126. https://doi.org/10.1016/0022-510x(95)00081-c</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(95)00081-c</ArticleId><ArticleId IdType="pubmed">7595602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, Murphy MF, Natter HM, Norris FH, Rudnicki SA (1997) Effect of recombinant human insulin-like growth factor-I on progression of ALS: a placebo-controlled study. Neurology 49(6):1621&#x2013;1630</Citation><ArticleIdList><ArticleId IdType="pubmed">9409357</ArticleId><ArticleId IdType="doi">10.1212/WNL.49.6.1621</ArticleId></ArticleIdList></Reference><Reference><Citation>Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, Silani V, Vos PE, Wokke JH, Dobbins T (1998) A placebo-controlled trial of insulin-like growth factor-i in amyotrophic lateral sclerosis. European als/igf-i study group. Neurology 51:583&#x2013;586</Citation><ArticleIdList><ArticleId IdType="pubmed">9710040</ArticleId><ArticleId IdType="doi">10.1212/WNL.51.2.583</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauverd M, Mitchell JD, Wokke JH, Borasio GD (2012) Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease. The Cochrane database of systematic reviews 11:CD002064. https://doi.org/10.1002/14651858.CD002064.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002064.pub3</ArticleId><ArticleId IdType="pubmed">23152212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson E, Windbank AJ, Mandrekar JN, Bamlet WR, Appel SH, Armon C, Barkhaus PE, Bosch P, Boylan K, David WS, Feldman E (2008) Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 71(22):1770&#x2013;1775</Citation><ArticleIdList><ArticleId IdType="pubmed">19029516</ArticleId><ArticleId IdType="pmc">2617770</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000335970.78664.36</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent AM, Mobley BC, Hiller A, Feldman EL (2004) Igf-i prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 16:407&#x2013;416</Citation><ArticleIdList><ArticleId IdType="pubmed">15193297</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2004.03.001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>